HIV Mutation Detail Information

> K103N Search Result


Mutation Information
Mutation Site K103N
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.Y181C+rt.K103N;rt.Y181C+rt.V106A+rt.K103N;rt.Y188C+rt.K103N;rt.V106A+rt.K103N
Relevant Drug nevirapine (NPV)
Country Uganda
Literature Information
PubMed PMID 18684096
Disease HIV infection/AIDS
Published Year 2008
Journal The Journal of infectious diseases
Title Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
Author Church JD,Omer SB,Guay LA,Huang W,Lidstrom J,Musoke P,Mmiro F,Jackson JB,Eshleman SH
Evidence We tested plasma HIV using a genotyping assay (ViroSeq), a phenotypic resistance assay (PhenoSense), and sensitive point mutation assay (LigAmp, for K103N, Y181C, G190A).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation